Amphastar Pharmaceuticals Income Taxes 2012-2024 | AMPH

Amphastar Pharmaceuticals income taxes from 2012 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.
Amphastar Pharmaceuticals Annual Income Taxes
(Millions of US $)
2023 $32
2022 $23
2021 $21
2020 $4
2019 $14
2018 $-3
2017 $-2
2016 $5
2015 $-8
2014 $-7
2013 $5
2012 $8
2011 $-40
2009 $12
Amphastar Pharmaceuticals Quarterly Income Taxes
(Millions of US $)
2024-09-30 $7
2024-06-30 $12
2024-03-31 $4
2023-12-31 $5
2023-09-30 $14
2023-06-30 $6
2023-03-31 $7
2022-12-31 $7
2022-09-30 $7
2022-06-30 $6
2022-03-31 $4
2021-12-31 $7
2021-09-30 $7
2021-06-30 $6
2021-03-31 $1
2020-12-31 $-1
2020-09-30 $2
2020-06-30 $-0
2020-03-31 $2
2019-12-31 $0
2019-09-30 $1
2019-06-30 $14
2019-03-31 $-1
2018-12-31 $-1
2018-09-30 $1
2018-06-30 $-1
2018-03-31 $-2
2017-12-31 $-2
2017-09-30 $-2
2017-06-30 $1
2017-03-31 $1
2016-12-31 $-1
2016-09-30 $2
2016-06-30 $3
2016-03-31 $1
2015-12-31 $3
2015-09-30 $-1
2015-06-30 $-4
2015-03-31 $-6
2014-12-31 $-3
2014-09-30 $-3
2014-06-30 $-1
2014-03-31 $-1
2013-12-31 $1
2013-09-30 $0
2013-06-30 $4
2013-03-31 $-0
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $1.738B $0.644B
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $24.935B 8.18
Dr Reddy's Laboratories (RDY) India $12.596B 24.10
BridgeBio Pharma (BBIO) United States $6.773B 0.00
Bausch Health Cos (BHC) Canada $2.792B 2.06
Supernus Pharmaceuticals (SUPN) United States $2.108B 28.70
Personalis (PSNL) United States $0.396B 0.00
Taysha Gene Therapies (TSHA) United States $0.314B 21.86
Assembly Biosciences (ASMB) United States $0.095B 0.00
Sol-Gel Technologies (SLGL) Israel $0.025B 0.00
Evoke Pharma (EVOK) United States $0.006B 0.00
Teligent (TLGT) United States $0.000B 0.00